Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
Nil Albiol, Carolina Martínez‐Laperche, Jorge Sierra, Josep F. Nomdedeu et al.
Citations
3 citations
Journal
Cancer
Topics
Chronic Lymphocytic Leukemia Research
Field-Weighted Citation Impact (FWCI)
1.31
article
Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy
Nil Albiol, Carolina Martínez‐Laperche, Jorge Sierra, Josep F. Nomdedeu, Miguel Arguello‐Tomas, Carol Moreno, Pablo Mozas, Juan A. Piñeyroa, Esther Moga, Sonia Osorio, Miguel López‐Esteban, Julio Delgado
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
CancerVol. 131(1)
Institutions
Universitat Autònoma de Barcelona (ES), Hospital de Sant Pau (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínic de Barcelona (ES), Fundación Josep Carreras Contra la Leucemia (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Institut de Recerca Sant Pau (ES), Universitat de Barcelona (ES)